HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 179 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,976,000 | -67.3% | 200,000 | -60.1% | 0.25% | -55.2% |
| Q3 2016 | $6,051,000 | -26.1% | 500,904 | -47.2% | 0.56% | -43.5% |
| Q2 2016 | $8,188,000 | -19.4% | 948,803 | -11.6% | 0.99% | -28.2% |
| Q1 2016 | $10,163,000 | -46.7% | 1,073,154 | -2.4% | 1.38% | -25.3% |
| Q4 2015 | $19,063,000 | +33.7% | 1,100,000 | +3.6% | 1.85% | +48.6% |
| Q3 2015 | $14,257,000 | -62.8% | 1,061,547 | -37.5% | 1.24% | -54.3% |
| Q2 2015 | $38,329,000 | +53.4% | 1,697,504 | -3.0% | 2.72% | +36.7% |
| Q1 2015 | $24,986,000 | -4.1% | 1,749,691 | -35.2% | 1.99% | +11.4% |
| Q4 2014 | $26,055,000 | +91.0% | 2,700,000 | +80.1% | 1.79% | +90.0% |
| Q3 2014 | $13,643,000 | +2.3% | 1,499,214 | +11.1% | 0.94% | +34.2% |
| Q2 2014 | $13,338,000 | – | 1,350,000 | – | 0.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRAN CAPITAL MANAGEMENT, L.P. | 1,084,118 | $61,686,285 | 7.80% |
| SNYDER CAPITAL MANAGEMENT L P | 3,983,814 | $226,679,017 | 5.12% |
| First Light Asset Management, LLC | 923,119 | $52,525,471 | 4.88% |
| Redwood Investments, LLC | 441,809 | $25,138,932 | 3.37% |
| BERNZOTT CAPITAL ADVISORS | 444,728 | $25,305,023 | 3.27% |
| DOHENY ASSET MANAGEMENT /CA | 46,050 | $2,620 | 3.04% |
| Crawford Lake Capital Management, LLC | 42,171 | $2,399,530 | 2.75% |
| 2Xideas AG | 416,586 | $23,703,743 | 2.51% |
| Granite Investment Partners, LLC | 902,882 | $51,373,986 | 2.14% |
| HighMark Wealth Management LLC | 41,790 | $2,377,851 | 1.79% |